RTP - Dr. Leroy Hood is recognized as one of the world's leading scientists in molecular biotechnology and genomics.  At the Biotech 2004 Conference in Research Triangle Park, North Carolina, Dr. Leroy Hood talks about the Institute for Systems Biology, which he helped to found.
    He also talks about the previous paradigm shifts in biotech research as well as possible future trends and predictions.


In this edition of the Biotech Show, we visit with Expression Analysis, a spin-out from the Howard Hughes Medical Institute (HHMI) at Duke University. 
    Founder and COO Steve Casey tells us about how the company helps research firms quickly find which parts of the human genome are being affected by their research compounds. 
  Casey also gives us a quick tour of the Expression Analysis labs

RTP - Dr. Bob Keefer of
BioPharma Consultants talks about doing business in Europe within the biotechnology and pharmaceutical industries.  He talks about what American and European partners are looking for in deals, current trends in European biotech, and the differences between the two scientific arenas and markets.
   Dr. Keefer has had extensive experience in working with biotech firms in Europe, especially in the German biotech regions.  An informative interview especially for American firms looking for partners or strategic investments overseas.

INTERVIEWS
We are looking for interviews with researchers, scientisits, and business leaders in the biotech community.  Interested?  Contact us!
Dr. Ralph Dean
Director of Fungal
Genomics at NCSU.

Dr. Ralph Dean, at
North Carolina State University's Center for Integrated Fungal Research, was one of the co-authors of a research paper in 2002 that described the sequencing of the rice genome.

We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.
RTP - We talk with well-known biotech leader Dr. John Ryals about his new company Metabolon. 
    After leaving Paradigm Genetics, the company he founded, Ryals started Metabolon to research the activity found in human cells on the biochemical level. 
     In this interview, Ryals gives us a quick look at the lab and talks about metabolomics versus his previous focus on genomics.

">
">
">
">
The Biotech Channel is brought to you by these important sponsors:
RTP - We talk with well-known biotech leader Dr. John Ryals about his new company Metabolon. 
    After leaving Paradigm Genetics, the company he founded, Ryals started Metabolon to research the activity found in human cells on the biochemical level. 
     In this interview, Ryals gives us a quick look at the lab and talks about metabolomics versus his previous focus on genomics.

We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.
Dr. Ralph Dean
Director of Fungal
Genomics at NCSU.

Dr. Ralph Dean, at
North Carolina State University's Center for Integrated Fungal Research, was one of the co-authors of a research paper in 2002 that described the sequencing of the rice genome.

sponsored by
INTERVIEWS
We are looking for interviews with researchers, scientisits, and business leaders in the biotech community.  Interested?  Contact us!
COPYRIGHT 2001-2004 RTP-TV
No reproduction or rebroadcast of video or audio content is allowed without the express written permission of RTP-TV



The Biotech Channel, biotechchannel.com, and RTP-TV are trademarks of Research Triangle Park Television
The Triangle TechJournal
Your source for biotech news in North Carolina
TriangleTechjournal.com
RTP, NC
Produced by Research Triangle Park Television:
RTPTV.COM
RTP, NC
919-522-3592
biotech@rtptv.com
Join our free e-mail list for website updates, events, news, and more. Privacy: we don't sell e-mail addresses to third parties, period.
RTP - Dr. Bob Keefer of
BioPharma Consultants talks about doing business in Europe within the biotechnology and pharmaceutical industries.  He talks about what American and European partners are looking for in deals, current trends in European biotech, and the differences between the two scientific arenas and markets.
   Dr. Keefer has had extensive experience in working with biotech firms in Europe, especially in the German biotech regions.  An informative interview especially for American firms looking for partners or strategic investments overseas.

In this edition of the Biotech Show, we visit with Expression Analysis, a spin-out from the Howard Hughes Medical Institute (HHMI) at Duke University. 
    Founder and COO Steve Casey tells us about how the company helps research firms quickly find which parts of the human genome are being affected by their research compounds. 
  Casey also gives us a quick tour of the Expression Analysis labs

RTP - Dr. Leroy Hood is recognized as one of the world's leading scientists in molecular biotechnology and genomics.  At the Biotech 2004 Conference in Research Triangle Park, North Carolina, Dr. Leroy Hood talks about the Institute for Systems Biology, which he helped to found.
    He also talks about the previous paradigm shifts in biotech research as well as possible future trends and predictions.


">
">
">
">
">
">
">
">
RTP - We talk with well-known biotech leader Dr. John Ryals about his new company Metabolon. 
    After leaving Paradigm Genetics, the company he founded, Ryals started Metabolon to research the activity found in human cells on the biochemical level. 
     In this interview, Ryals gives us a quick look at the lab and talks about metabolomics versus his previous focus on genomics.

We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.We visit with Norak Biosciences in Research Triangle Park to get a quick tour of their labs.  Norak is a Duke University spin-out biotech firm that uses a unique fluorescent technology to help identify drug targets in cells.  In particular, they're trying to identify drugs that regulate G protein-coupled receptors (GPCR's), which account for a majority of all of the prescription drugs on the market. 

Norak screens over 40,000 potential drug compounds a day using automated testing and robotics, and computerized data analysis.  This video is a good overview of what goes on in a modern biotech lab.
Dr. Ralph Dean
Director of Fungal
Genomics at NCSU.

Dr. Ralph Dean, at
North Carolina State University's Center for Integrated Fungal Research, was one of the co-authors of a research paper in 2002 that described the sequencing of the rice genome.

INTERVIEWS
We are looking for interviews with researchers, scientisits, and business leaders in the biotech community.  Interested?  Contact us!
RTP - Dr. Bob Keefer of
BioPharma Consultants talks about doing business in Europe within the biotechnology and pharmaceutical industries.  He talks about what American and European partners are looking for in deals, current trends in European biotech, and the differences between the two scientific arenas and markets.
   Dr. Keefer has had extensive experience in working with biotech firms in Europe, especially in the German biotech regions.  An informative interview especially for American firms looking for partners or strategic investments overseas.

In this edition of the Biotech Show, we visit with Expression Analysis, a spin-out from the Howard Hughes Medical Institute (HHMI) at Duke University. 
    Founder and COO Steve Casey tells us about how the company helps research firms quickly find which parts of the human genome are being affected by their research compounds. 
  Casey also gives us a quick tour of the Expression Analysis labs

RTP - Dr. Leroy Hood is recognized as one of the world's leading scientists in molecular biotechnology and genomics.  At the Biotech 2004 Conference in Research Triangle Park, North Carolina, Dr. Leroy Hood talks about the Institute for Systems Biology, which he helped to found.
    He also talks about the previous paradigm shifts in biotech research as well as possible future trends and predictions.